AIDS and Behavior

, Volume 19, Issue 8, pp 1430–1437

Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders

  • Vaughn E. Bryant
  • Nicole E. Whitehead
  • Larry E. BurrellII
  • Vonetta M. Dotson
  • Robert L. Cook
  • Paul Malloy
  • Kathryn Devlin
  • Ronald A. Cohen
Original Paper

Abstract

Depression and apathy are common among people living with HIV (PLWH). However, in PLWH, it is unclear whether depression and apathy are distinct conditions, which contribute to different patterns of disruption to cognitive processing and brain systems. Understanding these conditions may enable the development of prognostic indicators for HIV associated neurocognitive disorders (HAND). The present study examined substance use behavior and cognitive deficits, associated with depression and apathy, in 120 PLWH, using hierarchical regression analyses. Higher levels of depression were associated with a history of alcohol dependence and greater deficits in processing speed, motor and global cognitive functioning. Higher levels of apathy were associated with a history of cocaine dependence. It is recommended that PLWH get screened appropriately for apathy and depression, in order to receive the appropriate treatment, considering the comorbidities associated with each condition. Future research should examine the neurological correlates of apathy and depression in PLWH.

Keywords

HIV Depression Apathy Substance Cognition 

References

  1. 1.
    Dew MA, Becker JT, Sanchez J, Caldararo R, Lopez OL, Wess J, et al. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med. 1997;27(2):395–409.PubMedCrossRefGoogle Scholar
  2. 2.
    Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatr. 2001;158(5):725–30.PubMedCrossRefGoogle Scholar
  3. 3.
    Asch SM, Kilbourne AM, Gifford AL, Burnam MA, Turner B, Shapiro MF, et al. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med. 2003;18(6):450–60.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Wolff LC, Alvarado MR, Wolff RM. Prevalencia, factores de riesgo y manejo de la depresión en pacientes con infección por VIH: revisión de la literatura. Revista Chilena de Infectología. 2010;27:65–74.CrossRefGoogle Scholar
  5. 5.
    Judd F, Komiti A, Chua P, Mijch A, Hoy J, Grech P, et al. Nature of depression in patients with HIV/AIDS. Aust N Z J Psychiatr. 2005;39(9):826–32.CrossRefGoogle Scholar
  6. 6.
    Hoare J, Fouche JP, Spottiswoode B, Joska JA, Schoeman R, Stein DJ, et al. White matter correlates of apathy in HIV-positive subjects: a diffusion tensor imaging study. J Neuropsychiatr Clin Neurosci. 2010;22(3):313–20.CrossRefGoogle Scholar
  7. 7.
    Castellon SA, Hinkin CH, Myers HF. Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. J Int Neuropsychol Soc. 2000;6(3):336–47.PubMedCrossRefGoogle Scholar
  8. 8.
    Association AP. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.Google Scholar
  9. 9.
    Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatr Clin Neurosci. 1991;3(3):243–54.CrossRefGoogle Scholar
  10. 10.
    Tagariello P, Girardi P, Amore M. Depression and apathy in dementia: same syndrome or different constructs? A critical review. Arch Gerontol Geriatr. 2009;49(2):246–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Rabkin JG, Ferrando SJ, van Gorp W, Rieppi R, McElhiney M, Sewell M. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. J Neuropsychiatr Clin Neurosci. 2000;12(4):451–7.CrossRefGoogle Scholar
  12. 12.
    Castellon SA, Hinkin CH, Wood S, Yarema KT. Apathy, depression, and cognitive performance in HIV-1 infection. J Neuropsychiatr Clin Neurosci. 1998;10(3):320–9.CrossRefGoogle Scholar
  13. 13.
    Kamat R, Morgan E, Marcotte TD, Badiee J, Maich I, Cherner M, et al. Implications of apathy and depression for everyday functioning in HIV/AIDS in Brazil. J Affect Disord. 2013;150(3):1069–75.PubMedCrossRefGoogle Scholar
  14. 14.
    Wagner GJ, Goggin K, Remien RH, Rosen MI, Simoni J, Bangsberg DR, et al. A closer look at depression and its relationship to HIV antiretroviral adherence. Ann Behav Med. 2011;42(3):352–60.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26(1):40–9.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Tate D, Paul RH, Flanigan TP, Tashima K, Nash J, Adair C, et al. The impact of apathy and depression on quality of life in patients infected with HIV. AIDS Patient Care STDs. 2003;17(3):115–20.PubMedCrossRefGoogle Scholar
  17. 17.
    Cole MA, Castellon SA, Perkins AC, Ureno OS, Robinet MB, Reinhard MJ, et al. Relationship between psychiatric status and frontal-subcortical systems in HIV-infected individuals. J Int Neuropsychol Soc. 2007;13(3):549–54.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Fellows RP, Byrd DA, Morgello S, Manhattan HIVBB. Major depressive disorder, cognitive symptoms, and neuropsychological performance among ethnically diverse HIV+ men and women. J Int Neuropsychol Soc. 2013;19(2):216–25.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Bayon C, Ribera E, Cabrero E, Griffa L, Burgos A. Prevalence of depressive and other central nervous system symptoms in HIV-infected patients treated with HAART in Spain. J Int Assoc Phys AIDS Care. 2012;11(5):321–8.CrossRefGoogle Scholar
  20. 20.
    L’Akoa RM, Noubiap JJ, Fang Y, Ntone FE, Kuaban C. Prevalence and correlates of depressive symptoms in HIV-positive patients: a cross-sectional study among newly diagnosed patients in Yaounde, Cameroon. BMC Psychiatr. 2013;13:228.CrossRefGoogle Scholar
  21. 21.
    Malow R, Devieux JG, Stein JA, Rosenberg R, Jean-Gilles M, Attonito J, et al. Depression, substance abuse and other contextual predictors of adherence to antiretroviral therapy (ART) among Haitians. AIDS Behav. 2013;17(4):1221–30.PubMedCrossRefGoogle Scholar
  22. 22.
    Posada C, Moore DJ, Woods SP, Vigil O, Ake C, Perry W, et al. Implications of hepatitis C virus infection for behavioral symptoms and activities of daily living. J Clin Exp Neuropsychol. 2010;32(6):637–44.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Shapiro ME, Mahoney JR, Peyser D, Zingman BS, Verghese J. Cognitive Reserve Protects Against Apathy in Individuals with Human Immunodeficiency Virus. Arch Clin Neuropsychol. 2013;29(1):110–20.Google Scholar
  24. 24.
    Shapiro ME, Mahoney JR, Zingman BS, Pogge DL, Verghese J. Apathy correlates with cognitive performance, functional disability, and HIV RNA plasma levels in HIV-positive individuals. J Clin Exp Neuropsychol. 2013;35(9):934–45.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Kalechstein AD, Newton TF, Leavengood AH. Apathy syndrome in cocaine dependence. Psychiatry Res. 2002;109(1):97–100.PubMedCrossRefGoogle Scholar
  26. 26.
    Winhusen TM, Somoza EC, Lewis DF, Kropp FB, Horigian VE, Adinoff B. Frontal systems deficits in stimulant-dependent patients: evidence of pre-illness dysfunction and relationship to treatment response. Drug Alcohol Depend. 2013;127(1–3):94–100.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Paul R, Flanigan TP, Tashima K, Cohen R, Lawrence J, Alt E, et al. Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus. J Neuropsychiatr Clin Neurosci. 2005;17(1):114–8.CrossRefGoogle Scholar
  28. 28.
    Devlin KN, Gongvatana A, Clark US, Chasman JD, Westbrook ML, Tashima KT, et al. Neurocognitive effects of HIV, hepatitis C, and substance use history. J Int Neuropsychol Soc. 2012;18(1):68–78.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Bryant VE, Kahler CW, Devlin KN, Monti PM, Cohen RA. The effects of cigarette smoking on learning and memory performance among people living with HIV/AIDS. AIDS Care. 2013;25(10):1308–16.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Robins LN, Wing J, Wittchen H, et al. The composite international diagnostic interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatr. 1988;45(12):1069–77.PubMedCrossRefGoogle Scholar
  31. 31.
    Kellogg SH, McHugh PF, Bell K, Schluger JH, Schluger RP, LaForge KS, et al. The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend. 2003;69(2):137–50.PubMedCrossRefGoogle Scholar
  32. 32.
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.CrossRefGoogle Scholar
  33. 33.
    Grace J, Malloy P, Psychological Assessment Resources I. FrSBe, Frontal Systems Behavior Scale: Professional Manual: Psychological Assessment Resources; 2001.Google Scholar
  34. 34.
    Lane-Brown AT, Tate RL. Measuring apathy after traumatic brain injury: psychometric properties of the apathy evaluation scale and the frontal systems behavior scale. Brain Injury. 2009;23(13–14):999–1007.PubMedCrossRefGoogle Scholar
  35. 35.
    Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins verbal learning test—revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12(1):43–55.CrossRefGoogle Scholar
  36. 36.
    Brandt J, Benedict RHB. Hopkins verbal learning test-revised (HVLT-R). Lutz: Psychological Assessment Resources, Inc.; 1991.Google Scholar
  37. 37.
    Benedict RHB. Brief Visuospatial Memory Test-Revised. Odessa: Psychological Assessment Resources; 1997.Google Scholar
  38. 38.
    Benton AL, Hamsher K, Sivan AB. Multilingual aphasia examination. Iowa City: AJA Associates; 1994.Google Scholar
  39. 39.
    Golden CJ. Stroop color and word test. Chicago: Stoelting; 1978.Google Scholar
  40. 40.
    Reitan RM. Trail Making Test. Tucson: Reitan Neuropsychology Laboratory; 1992.Google Scholar
  41. 41.
    Kløve H. Grooved Pegboard. Lafeyette: Lafeyette Instruments; 1963.Google Scholar
  42. 42.
    Wechsler D. Wechsler Adult Intelligence Scale-III (WAIS-III). San Antonio: The Psychological Corporation; 1997.Google Scholar
  43. 43.
    Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26(3):307–19.PubMedCrossRefGoogle Scholar
  44. 44.
    Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3–16.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Benedict RHB, Schretlen D, Groninger L, Dobraski M, Shpritz B. Revision of the brief visuospatial memory test: studies of normal performance, reliability, and validity. Psychol Assess. 1996;8(2):145–53.CrossRefGoogle Scholar
  46. 46.
    Heaton RK, Taylor MJ, Grant I. Revised comprehensive norms for an expanded Halstead-Reitan battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz: Psychological Assessment Resources; 2004.Google Scholar
  47. 47.
    Mirowsky J, Ross CE. Age and Depression. J Health Soc Behav. 1992;33(3):187–205.PubMedCrossRefGoogle Scholar
  48. 48.
    Starkstein SE, Jorge R, Mizrahi R, Robinson RG. A prospective longitudinal study of apathy in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2006;77(1):8–11.PubMedCentralPubMedCrossRefGoogle Scholar
  49. 49.
    Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–99.PubMedCentralPubMedCrossRefGoogle Scholar
  50. 50.
    Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991;38(2):143–62.PubMedCrossRefGoogle Scholar
  51. 51.
    Poudel-Tandukar K, Bertone-Johnson ER, Palmer PH, Poudel KC. C-reactive protein and depression in persons with Human Immunodeficiency Virus infection. Brain Beha Immun. 2014.Google Scholar
  52. 52.
    Del Guerra FB, Fonseca JL, Figueiredo VM, Ziff EB, Konkiewitz EC. Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways. Journal of neurovirology. 2013;19(4):314–27.PubMedCrossRefGoogle Scholar
  53. 53.
    Ances BM, Letendre SL, Alexander T, Ellis RJ. Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders. Int Rev Psychiatry. 2008;20(1):89–93.PubMedCrossRefGoogle Scholar
  54. 54.
    Ishizaki J, Mimura M. Dysthymia and apathy: diagnosis and treatment. Depression research and treatment. 2011;2011:893905.PubMedCentralPubMedCrossRefGoogle Scholar
  55. 55.
    Padala PR, Burke WJ, Bhatia SC, Petty F. Treatment of apathy with methylphenidate. J Neuropsychiatr Clin Neurosci. 2007;19(1):81–3.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Vaughn E. Bryant
    • 1
  • Nicole E. Whitehead
    • 1
  • Larry E. BurrellII
    • 1
  • Vonetta M. Dotson
    • 1
  • Robert L. Cook
    • 2
  • Paul Malloy
    • 3
  • Kathryn Devlin
    • 4
  • Ronald A. Cohen
    • 5
    • 1
  1. 1.Department of Clinical and Health PsychologyUniversity of FloridaGainesvilleUSA
  2. 2.Department of EpidemiologyUniversity of FloridaGainesvilleUSA
  3. 3.Department of Psychiatry and Human BehaviorBrown UniversityProvidenceUSA
  4. 4.Department of PsychologyTemple UniversityPhiladelphiaUSA
  5. 5.Department of Aging and Geriatric ResearchUniversity of FloridaGainesvilleUSA

Personalised recommendations